BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36864833)

  • 1. A clinical observation study on the effect of needle-free insulin syringe on blood glucose control and well-being index in patients with early-onset type 2 diabetes mellitus.
    Jin X; Sun Q; Yue C; Han J; Zhou X; Guan Q; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1137179. PubMed ID: 36864833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Kong X; Luo M; Cai L; Zhang P; Yan R; Hu Y; Li H; Ma J
    Expert Opin Drug Deliv; 2021 May; 18(5):635-641. PubMed ID: 33317342
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of a needle-free injector in Chinese patients with type 2 diabetes mellitus treated with basal insulin: a multicentre, prospective, randomised, crossover study.
    Xing Y; Xie X; Xu J; Liu J; He Q; Yang W; Zhang N; Li X; Wang L; Fu J; Zhou J; Gao B; Ming J; Liu X; Lai J; Liu T; Shi M; Ji Q
    Expert Opin Drug Deliv; 2019 Sep; 16(9):995-1002. PubMed ID: 31359813
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen.
    Sun Y; Wang J; Li H; Sun X; Su X; Ma J
    Expert Opin Drug Deliv; 2020 May; 17(5):713-717. PubMed ID: 32141347
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals.
    Pan Q; Zhang L; Gu A; Yu D; Wang X; Zhou Y; Guo L
    Front Endocrinol (Lausanne); 2022; 13():832726. PubMed ID: 35574009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.
    Engwerda EE; Tack CJ; de Galan BE
    Diabetes Care; 2013 Nov; 36(11):3436-41. PubMed ID: 24089542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study.
    De Berardis G; Scardapane M; Lucisano G; Abbruzzese S; Bossi AC; Cipponeri E; D'Angelo P; Fontana L; Lancione R; Marelli G; Sciangula L; Nicolucci A
    Curr Med Res Opin; 2018 Sep; 34(9):1699-1704. PubMed ID: 29924641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
    Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Rahman MM; Asaduzzaman M; Mustari M; Paul AK; Kabir ML; Chowdhury SR; Talukder SK; Sarkar S; Hannan MA; Islam MR; Iftekhar MH; Robel MAB; Selim S
    BMC Endocr Disord; 2023 Feb; 23(1):37. PubMed ID: 36782190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.
    Dunbar JM; Madden PM; Gleeson DT; Fiad TM; McKenna TJ
    Diabetes Care; 1994 Aug; 17(8):874-8. PubMed ID: 7956634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study).
    Ji L; Gao L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    EClinicalMedicine; 2020 Jun; 23():100368. PubMed ID: 32529176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes.
    Wu Q; Deng M; Wang W; Yu S; Wang M; Sun C; Pan Q; Guo L
    Front Endocrinol (Lausanne); 2023; 14():1162176. PubMed ID: 37501783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.
    Seggelke SA; Hawkins RM; Gibbs J; Rasouli N; Wang CC; Draznin B
    Endocr Pract; 2014 Jun; 20(6):536-9. PubMed ID: 24326004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.